Dissecting the MAPK signaling landscape in malignant melanoma: from BRAF and NRAS mutations to precision combination therapies

Malignant melanoma is an aggressive skin malignancy with a complex molecular landscape and limited treatment durability in advanced stages. Aberrations in the MAPK pathway—most notably BRAF and NRAS mutations—have catalyzed the development of targeted therapies, particularly BRAF/MEK inhibitors, whi...

Descripció completa

Dades bibliogràfiques

Autors principals:	Xiaobo Fang, Shuangyin Wang, Shuangxing Fu
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2026-01-01
Col·lecció:	Frontiers in Cell and Developmental Biology
Matèries:	BRAF inhibitors combination therapy MAPK pathway melanoma NRAS mutations precision medicine
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fcell.2025.1723066/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!